acetylcysteine has been researched along with pulmicort in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Eriksson, C; Jansson, AH; Wang, X | 1 |
| Balansky, R; Croce, CM; D'Agostini, F; De Flora, S; Di Marco, B; Ganchev, G; Izzotti, A; Lubet, RA; Zanesi, N | 1 |
| Kamin, W; Krämer, I; Schwabe, A | 1 |
| Akapo, S; Gupta, J; Martinez, E; McCrea, C; Roach, M; Ye, L | 1 |
| de Vries, EG; Homan, S; Postma, DS; Scheper, RJ; Timens, W; Timmer-Bosscha, H; van der Deen, M | 1 |
| Bill, W; Bonasia, PJ; McVicar, WK; Ong, S | 1 |
| Balansky, R; De Flora, S; Ganchev, G; Iltcheva, M; Steele, VE | 1 |
| Calkovska, A; Drgova, A; Kopincova, J; Mokra, D; Pullmann, R | 1 |
| Li, Q; Li, Y; Lv, M; Lv, S; Yu, H; Zou, K | 1 |
| Chen, C; Liu, K; Wang, Y; Zhang, C | 1 |
| Lv, M; Lv, S; Qian, Y; Yu, H; Zhang, S; Zou, K | 1 |
| Chen, J; Liu, Q; Zhao, W; Zheng, C; Zhu, Y | 1 |
2 review(s) available for acetylcysteine and pulmicort
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
Topics: Acetylcysteine; Administration, Inhalation; Albuterol; Anti-Asthmatic Agents; Anti-Bacterial Agents; Asthma; Bronchodilator Agents; Budesonide; Colistin; Cromolyn Sodium; Cystic Fibrosis; Deoxyribonuclease I; Drug Therapy, Combination; Expectorants; Humans; Ipratropium; Nebulizers and Vaporizers; Respiratory Therapy; Tobramycin | 2006 |
18 other study(ies) available for acetylcysteine and pulmicort
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Chemokine CCL2; Chemokine CXCL1; Chemokine CXCL2; Chemokines, CXC; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Instillation, Drug; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lung; Organ Size; Pneumonia; Rats; Rats, Wistar; Respiratory Distress Syndrome; Total Lung Capacity; Tumor Necrosis Factor-alpha | 2005 |
Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.
Topics: Acetylcysteine; Acid Anhydride Hydrolases; Alopecia Areata; Animals; Anti-Inflammatory Agents; Benzo(a)pyrene; Budesonide; Female; Genes, Tumor Suppressor; Lung; Mice; Mice, Inbred Strains; Neoplasm Proteins; Neoplasms; Stomach | 2006 |
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Topics: Acetylcysteine; Aerosols; Anti-Asthmatic Agents; Bronchodilator Agents; Budesonide; Chromatography, High Pressure Liquid; Cromolyn Sodium; Drug Incompatibility; Drug Stability; Ethanolamines; Expectorants; Formoterol Fumarate; Humans; Hydrogen-Ion Concentration; Ipratropium; Nebulizers and Vaporizers; Osmolar Concentration; Particle Size; Pulmonary Disease, Chronic Obstructive; Time Factors | 2008 |
Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.
Topics: Acetylcysteine; Biological Transport; Bronchi; Bronchodilator Agents; Budesonide; Cholinergic Antagonists; Drug Resistance, Multiple; Epithelial Cells; Ethanolamines; Expectorants; Flow Cytometry; Formoterol Fumarate; Humans; In Vitro Techniques; Ipratropium; Multidrug Resistance-Associated Proteins; Oxidative Stress; Pulmonary Disease, Chronic Obstructive | 2008 |
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
Topics: Acetylcysteine; Administration, Inhalation; Albuterol; Budesonide; Cromolyn Sodium; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Ipratropium; Respiratory System Agents; Time Factors | 2008 |
Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Animals, Newborn; Anticarcinogenic Agents; Budesonide; Disease Models, Animal; Female; Isothiocyanates; Lung Neoplasms; Male; Mice; Tobacco Smoke Pollution | 2010 |
Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Aminophylline; Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Fluid; Budesonide; Dexamethasone; Disease Models, Animal; Humans; Imidazoles; Infant, Newborn; Leukocyte Count; Lung; Meconium; Meconium Aspiration Syndrome; Neutrophils; Oxidative Stress; Phosphodiesterase Inhibitors; Pulmonary Edema; Pulmonary Surfactants; Pyridones; Rabbits | 2013 |
Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Budesonide; Eosine Yellowish-(YS); Hematoxylin; Lipopolysaccharides; MicroRNAs; Neutrophil Infiltration; Rats; RNA, Messenger; Suppressor of Cytokine Signaling 3 Protein | 2022 |
Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation.
Topics: Acetylcysteine; Ambroxol; Budesonide; Child; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Retrospective Studies | 2023 |
Combination therapy with budesonide and acetylcysteine alleviates LPS-induced acute lung injury via the miR-381/NLRP3 molecular axis.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Budesonide; Lipopolysaccharides; Lung; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Edema; Rats; Signal Transduction | 2023 |
Clinical efficacy of budesonide combined with acetylcysteine in the treatment of mycoplasma pneumonia infection.
Topics: Acetylcysteine; Budesonide; Child; Cough; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Treatment Outcome | 2023 |